Similarities were also noted between CLBL-1 and other targeted B-cell lymphoma gene expression studies, including KIT (almost 400-fold based on qRT-PCR) [60] and ZAP70 downregulation (decreased 10 fold) [61]. The gene discussed is KIT; the disease is B-cell non-Hodgkin lymphoma.